Skip to main content
Clinical Trials/IRCT2017070922965N11
IRCT2017070922965N11RecruitingPhase 3

Comparative Effectiveness of Atorvastatin 5% lotion vs betamethasone lotion in treatment of seborrheic dermatitis in adult: Double blind Randomized Clinical trial study

vice chancellor for research,Hamadan University of Medical Sciences0 sites70 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • inclusion criteria:Patients with seborrheic dermatitis in the scalp and face with clinical diagnosis?Lack of treatment with topical or systemic corticosteroids?Methyl dopa? Chlorpromazine?Topical or systemic acne medications from a month before referral?Failure to develop a systemic disorder, such as Parkinson's disease, AIDS, mood disorders.
  • exclusion criteria:Report any allergy to the drug, such as Contact dermatitis?Dissatisfaction with drug use and collaborative study?Lack of referral for follow up and observation of the therapeutic efficacy of the drug?Having a very severe type of disease(Itching score greater than 7)?Pregnancy and lactation

Exclusion Criteria

  • Not provided

Investigators

Sponsor
vice chancellor for research,Hamadan University of Medical Sciences

Similar Trials